Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLAM.L Regulatory News (LAM)

  • There is currently no data for LAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Lamprell plc

7 Jul 2022 16:05

RNS Number : 7463R
Lamprell plc
07 July 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Lamprell plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Lamprell plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

6 July 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 5 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests in Lamprell shares held by the directors of Lamprell plc and their close persons and related trusts:

 

Lamprell Director

Role

Number of ordinary shares

Percentage of total issued share capital (3 decimal places)

Christopher McDonald

Chief Executive Officer

942,085

0.156%

Antony Wright

Chief Financial Officer

179,641

0.044%

Mel Fitzgerald

Non-Executive Director

111,700

0.027%

John Malcolm

Non-Executive Chairman

100,000

0.024%

Debra Valentine

Senior Independent Director

75,000

0.018%

 

(b) Retention Share Plan awards

 

Lamprell Director

Role

Date of grant

Exercise price

Number of ordinary shares over which rights have been granted and are outstanding

Date Of vesting

Christopher McDonald

Chief Executive Officer

29 November 2021

Nil

995,199

28 November 2024

Antony Wright

Chief Financial Officer

29 November 2021

Nil

466,322

28 November 2024

 

(c) Performance Share Plan awards

 

Lamprell Director

Role

Date of grant

Exercise price

Number of ordinary shares over which rights have been granted and are outstanding

Date Of vesting

Christopher McDonald

Chief Executive Officer

29 November 2021

Nil

1,990,398

28 November 2024

5 April 2019

Nil

1,402,399

4 April 2022*

Antony Wright

Chief Financial Officer

29 November 2021

Nil

932,644

28 November 2024

5 April 2019

Nil

657,124

4 April 2022*

 

*Note: Performance conditions to be tested and awards to be satisfied based on same.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

7 July 2022

Contact name:

Alexander Ridout, General Counsel and Company Secretary

Telephone number:

+971 4 803 9326

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEASXXEELAEFA
Date   Source Headline
10th Jun 201411:49 amRNSResult of EGM
10th Jun 201410:04 amRNSResult of AGM
9th Jun 20147:01 amRNSHolding(s) in Company
9th Jun 20147:00 amRNSHolding(s) in Company
9th Jun 20147:00 amRNSHolding(s) in Company
27th May 20147:00 amRNSContract Award
16th May 201412:00 pmRNSPublication of Prospectus
16th May 20147:00 amRNSInterim Management Statement
16th May 20147:00 amRNSRights Issue
29th Apr 20147:00 amRNSNotice of AGM/Annual Report and Accounts
15th Apr 20142:27 pmRNSContract Award
26th Mar 20147:00 amRNS2013 Financial Results
14th Mar 20147:00 amRNSNotice of Results
3rd Mar 20147:02 amRNSDisposal of Inspec service business
3rd Mar 20147:02 amRNSAcquisition
14th Feb 20147:00 amRNSDirectorate Change
16th Jan 20147:00 amRNSTrading Statement
14th Nov 20137:00 amRNSInterim Management Statement
8th Nov 20137:00 amRNSDelivery of Caspian Sea rig
18th Oct 20137:00 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSArrival of new CFO
19th Sep 201310:00 amRNSHolding(s) in Company
16th Sep 20137:00 amRNSHolding(s) in Company
13th Sep 20137:00 amRNSContract Award
30th Aug 20137:00 amRNSContract Award
29th Aug 20137:00 amRNSHalf Yearly Results
28th Aug 20137:00 amRNSDirectorate Change
23rd Aug 201312:58 pmRNSNotice of Results
1st Aug 20137:00 amRNSUpdate on Refinancing of Debt Facilities
19th Jul 20137:00 amRNSUpdate on Refinancing of Debt Facilities
17th Jun 20137:00 amRNSRefinancing of Debt Facilities
28th May 20137:00 amRNSResult of AGM
17th May 20137:00 amRNSInterim Management Statement
29th Apr 201312:00 pmRNSDirectorate Change
29th Apr 201312:00 pmRNSNotice of AGM/Annual Report and Accounts
22nd Mar 20139:00 amRNSNotice of AGM
21st Mar 20137:00 amRNSAppointment of CFO
21st Mar 20137:00 amRNSFinal Results
19th Mar 20133:25 pmRNSDirectorate Appointment
18th Mar 20138:24 amRNSSettlement of FSA Investigation
4th Mar 20137:00 amRNSArrival of New CEO
18th Feb 20137:00 amRNSDelivery of Windcarrier 2
6th Feb 20137:00 amRNSContract Award
31st Jan 20137:00 amRNSTrading Update
2nd Jan 20139:13 amRNSReplacement - Banking Waivers and Contracts Update
2nd Jan 20138:36 amRNSBanking Waivers and Contracts Update
31st Dec 20127:00 amRNSHolding(s) in Company
18th Dec 20124:45 pmRNSHolding(s) in Company
6th Dec 20124:45 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Dec 20127:30 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.